Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (91-100 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|April 20, 2010
Detecting low level sequence variants in recombinant monoclonal antibodiesYi Yang, Alex Strahan, Charlene Li, et al.
Mabs|September 15, 2016
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibodyJames R Apgar, Michelle Mader, Rita Agostinelli, et al.
Mabs|September 3, 2016
Characterizing monoclonal antibody formulations in arginine glutamate solutions using <sup>1</sup>H NMR spectroscopyPriscilla Kheddo, Matthew J Cliff, Shahid Uddin, et al.
Mabs|September 10, 2016
Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodiesTetyana Dashivets, Jan Stracke, Stefan Dengl, et al.
Mabs|June 6, 2017
Enhanced immunization techniques to obtain highly specific monoclonal antibodiesRodrigo de Almeida, Cecília Naomi Nakamura, Marina de Lima Fontes, et al.
Mabs|June 6, 2017
Impact of S-sulfocysteine on fragments and trisulfide bond linkages in monoclonal antibodiesRonja Seibel, Sandra Maier, Alisa Schnellbaecher, et al.
Mabs|June 8, 2017
Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibodyYin Luo, Stephen W Raso, Judith Gallant, et al.
Mabs|March 2, 2010
Catumaxomab: clinical development and future directionsRolf Linke, Anke Klein, Diane Seimetz
Mabs|June 16, 2017
Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stabilityMarie-Therese Schermeyer, Anna K Wöll, Bas Kokke, et al.
Pageof 184

Showing results (91-100 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|April 20, 2010
Therapeutic antibodies, vaccines and antibodyomesDimiter S Dimitrov
Mabs|April 20, 2010
Detecting low level sequence variants in recombinant monoclonal antibodiesYi Yang, Alex Strahan, Charlene Li, et al.
Mabs|September 15, 2016
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibodyJames R Apgar, Michelle Mader, Rita Agostinelli, et al.
Mabs|September 3, 2016
Characterizing monoclonal antibody formulations in arginine glutamate solutions using <sup>1</sup>H NMR spectroscopyPriscilla Kheddo, Matthew J Cliff, Shahid Uddin, et al.
Mabs|September 10, 2016
Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodiesTetyana Dashivets, Jan Stracke, Stefan Dengl, et al.
Mabs|June 6, 2017
Enhanced immunization techniques to obtain highly specific monoclonal antibodiesRodrigo de Almeida, Cecília Naomi Nakamura, Marina de Lima Fontes, et al.
Mabs|June 6, 2017
Impact of S-sulfocysteine on fragments and trisulfide bond linkages in monoclonal antibodiesRonja Seibel, Sandra Maier, Alisa Schnellbaecher, et al.
Mabs|June 8, 2017
Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibodyYin Luo, Stephen W Raso, Judith Gallant, et al.
Mabs|March 2, 2010
Catumaxomab: clinical development and future directionsRolf Linke, Anke Klein, Diane Seimetz
Mabs|June 16, 2017
Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stabilityMarie-Therese Schermeyer, Anna K Wöll, Bas Kokke, et al.
Pageof 184